Self-renewal as a therapeutic target in human colorectal cancer

Prospective identification of tumorigenic breast cancer cells

Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,388 · see citing works

Identification of human brain tumour initiating cells

Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,388 · see citing works

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,363 · see citing works

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

O'Brien, C. A., Pollett, A. F., Gallinger, S., & Dick, J. E. (2006) · Nature · doi:10.1038/nature05372 · Cited by 4,089 · see citing works

Identification and expansion of human colon-cancer-initiating cells

Ricci‐Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & Maria, R. D. (2006) · Nature · doi:10.1038/nature05384 · Cited by 4,001 · see citing works

Phenotypic characterization of human colorectal cancer stem cells

Dalerba, P. D., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A. L., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,187 · see citing works

ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays

Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,091 · see citing works

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.

Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871 · see citing works

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804 · see citing works

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

Li, X., Lewis, M. T., Huang, J., Gutiérrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A. C., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · see citing works

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752 · see citing works

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.

Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452 · see citing works

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

Molofsky, A. V., Pardal, R., Iwashita, T., Park, I.-K., Clarke, M. F., & Morrison, S. J. (2003) · Nature · doi:10.1038/nature02060 · Cited by 1,301 · see citing works

Polycomb silencers control cell fate, development and cancer

Sparmann, A., & van Lohuizen, M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1991 · Cited by 1,294 · see citing works

Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

Shimono, Y., Zabala, M., Cho, R. W., Lobo, N. A., Dalerba, P. D., Qian, D., Diehn, M., Liu, H., Panula, S., Chiao, E. T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,205 · see citing works

A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable

Tian, H., Biehs, B., Warming, S., Leong, K. G., Rangell, L. K., Klein, O. D., & de Sauvage, F. J. (2011) · Nature · doi:10.1038/nature10408 · Cited by 1,194 · see citing works

Bmi1 is expressed in vivo in intestinal stem cells

Sangiorgi, E., & Capecchi, M. R. (2008) · Nature Genetics · doi:10.1038/ng.165 · Cited by 1,192 · see citing works

Stem cell concepts renew cancer research.

Dick, J. (2008) · Blood · doi:10.1182/blood-2008-08-077941 · Cited by 1,126 · see citing works

Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4

Todaro, M., Alea, M. P., Stefano, A. B. D., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A. D., Gulotta, G., Medema, J. P., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,040 · see citing works

Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer

Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C. F., et al. (2012) · Science · doi:10.1126/science.1227670 · Cited by 738 · see citing works

Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer

Sauvageau, M., & Sauvageau, G. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.08.002 · Cited by 676 · see citing works

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith‐Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589 · see citing works

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

Leung, C., Lingbeek, M., Shakhova, O., Liu, J. K., Tanger, E., Saremaslani, P., van Lohuizen, M., & Marino, S. (2004) · Nature · doi:10.1038/nature02385 · Cited by 541 · see citing works

Targeting Breast Cancer Stem Cells

Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 360 · see citing works

Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters

Amendola, M., Venneri, M. A., Biffi, A., Vigna, E., & Naldini, L. (2004) · Nature Biotechnology · doi:10.1038/nbt1049 · Cited by 324 · see citing works

BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal

Abdouh, M., Facchino, S., Chatoo, W., Balasingam, V., Ferreira, J., & Bernier, G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0968-09.2009 · Cited by 323 · see citing works

Bmi1 Controls Tumor Development in an Ink4a/Arf-Independent Manner in a Mouse Model for Glioma

Bruggeman, S. W. M., Hulsman, D., Tanger, E., Buckle, T., Blom, M., Zevenhoven, J., van Tellingen, O., & van Lohuizen, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.032 · Cited by 290 · see citing works

Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation

Lukacs, R. U., Memarzadeh, S., Wu, H., & Witte, O. N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.11.013 · Cited by 268 · see citing works

Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission

Tehranchi, R., Woll, P. S., Anderson, K., Buza-Vidas, N., Mizukami, T., Mead, A. J., Åstrand‐Grundström, I., Strömbeck, B., Horvat, A., Ferry, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912228 · Cited by 253 · see citing works

The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins

Kim, J. H., Yoon, S. Y., Kim, C.-N., Joo, J. H., Moon, S. K., Choe, I. S., Choe, Y., & Kim, J. W. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.07.009 · Cited by 247 · see citing works

ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21

O'Brien, C. A., Kreso, A., Ryan, P. M., Hermans, K. G., Gibson, L., Wang, Y., Tsatsanis, A., Gallinger, S., & Dick, J. E. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.036 · Cited by 222 · see citing works

Mechanisms of Disease: Cancer stem cells--targeting the evil twin

Trumpp, A., & Wiestler, O. D. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1110 · Cited by 199 · see citing works

The tumor-suppressive functions of the human INK4A locus

Voorhoeve, P. M., & Agami, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00223-x · Cited by 194 · see citing works

The Polycomb Gene Product BMI1 Contributes to the Maintenance of Tumor-Initiating Side Population Cells in Hepatocellular Carcinoma

Chiba, T., Miyagi, S., Saraya, A., Aoki, R., Seki, A., Morita, Y., Yonemitsu, Y., Yokosuka, O., Taniguchi, H., Nakauchi, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5882 · Cited by 194 · see citing works

Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion

Dovey, J. S., Zacharek, S. J., Kim, C. F., & Lees, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803574105 · Cited by 174 · see citing works

Therapeutic Implications of the Cancer Stem Cell Hypothesis

Diehn, M., Cho, R. W., & Clarke, M. F. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.002 · Cited by 147 · see citing works

Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer

Li, D., Tang, H., Fan, J., Yan, D., Zhou, C., Li, S., Wang, X., & Peng, Z. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0745-7 · Cited by 119 · see citing works

Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm.

Wang, J. C. Y. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.10.005 · Cited by 70 · see citing works

Dysregulated Expression of Stem Cell Factor Bmi1 in Precancerous Lesions of the Gastrointestinal Tract

Tateishi, K., Ohta, M., Kanai, F., Guleng, B., Tanaka, Y., Asaoka, Y., Tada, M., Seto, M., Jazag, A., Lianjie, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0449 · Cited by 67 · see citing works

Colon Cancer Stem Cells

Kreso, A., & O'Brien, C. A. (2008) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc0301s7 · Cited by 63 · see citing works

Targeting cancer stem cells

Kvinlaug, B. T., & Huntly, B. J. P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.7.915 · Cited by 62 · see citing works

Polycomb group protein Bmi1 expression in colon cancers predicts the survival

Du, J., Li, Y., Li, J., & Zheng, J. (2009) · Medical Oncology · doi:10.1007/s12032-009-9373-y · Cited by 54 · see citing works

Cancer stem cells revisited

Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769 · see citing works

Evolution of the Cancer Stem Cell Model

Kreso, A., & Dick, J. E. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,212 · see citing works

DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts

Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S. Y., Han, H., Liang, G., Jones, P. A., Pugh, T. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.056 · Cited by 1,527 · see citing works

Cancer Stem Cells: Basic Concepts and Therapeutic Implications

Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869 · see citing works

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Filbin, M. G., Tirosh, I., Hovestadt, V., Shaw, M. L., Escalante, L. E., Mathewson, N. D., Neftel, C., Frank, N., Pelton, K., Hebert, C. M., et al. (2018) · Science · doi:10.1126/science.aao4750 · Cited by 679 · see citing works

Stem cell programs in cancer initiation, progression, and therapy resistance

Huang, T., Song, X., Xu, D., Tiek, D., Goenka, A., Wu, B., Sastry, N., Hu, B., & Cheng, S.-Y. (2020) · Theranostics · doi:10.7150/thno.41648 · Cited by 524 · see citing works

Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy

Rehman, S. K., Haynes, J., Collignon, E., Brown, K. R., Wang, Y., Nixon, A. M. L., Bruce, J. P., Wintersinger, J. A., Singh Mer, A., Lo, E. B. L., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.018 · Cited by 495 · see citing works

Classifying the evolutionary and ecological features of neoplasms

Maley, C. C., Aktipis, A., Graham, T. A., Sottoriva, A., Boddy, A. M., Janiszewska, M., Silva, A. S., Gerlinger, M., Yuan, Y., Pienta, K. J., et al. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.69 · Cited by 423 · see citing works

Evolutionary Determinants of Cancer

Greaves, M. F. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0439 · Cited by 411 · see citing works

Targeting glioma stem cells through combined BMI1 and EZH2 inhibition

Jin, X., Kim, L. J. Y., Wu, Q., Wallace, L. C., Prager, B. C., Sanvoranart, T., Gimple, R. C., Wang, X., Mack, S. C., Miller, T. E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4415 · Cited by 379 · see citing works

The roles of Polycomb repressive complexes in mammalian development and cancer

Piunti, A., & Shilatifard, A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00341-1 · Cited by 382 · see citing works

Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells

Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 380 · see citing works

Colorectal Cancer Stem Cells: From the Crypt to the Clinic

Zeuner, A., Todaro, M., Stassi, G., & Maria, R. D. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.11.012 · Cited by 370 · see citing works

DNA Damage in Stem Cells

Vitale, I., Manic, G., De Maria, R., Kroemer, G., & Galluzzi, L. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.006 · Cited by 361 · see citing works

Chromatin repressive complexes in stem cells, development, and cancer

Laugesen, A., & Helin, K. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.006 · Cited by 352 · see citing works

Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts

Cassidy, J. W., Caldas, C., & Bruna, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0727 · Cited by 346 · see citing works

Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity

Wainwright, E. N., & Scaffidi, P. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.004 · Cited by 293 · see citing works

Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency

Mehdipour, P., Marhon, S. A., Ettayebi, I., Chakravarthy, A., Hosseini, A., Wang, Y., de Castro, F. A., Yau, H. L., Ishak, C. A., Abelson, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2844-1 · Cited by 298 · see citing works

Targeting BMI1 + Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma

Chen, D., Wu, M.-S., Yang, L., Chang, I., Yuan, Q., Salvo, M. E., Deng, P., Yu, B., Yu, Y.-X., Dong, J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.02.003 · Cited by 278 · see citing works

Determinants of metastatic competency in colorectal cancer

Tauriello, D. V. F., Calon, A., Lonardo, E., & Batlle, E. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12018 · Cited by 257 · see citing works

Common stemness regulators of embryonic and cancer stem cells

Hadjimichael, C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i9.1150 · Cited by 246 · see citing works

Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance

Adorno-Cruz, V., Kibria, G., Liu, X., Doherty, M. R., Junk, D. J., Guan, D., Hubert, C., Venere, M., Mulkearns-Hubert, E. E., Sinyuk, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3225 · Cited by 238 · see citing works

Isolation, identification, and characterization of cancer stem cells: A review

Abbaszadegan, M. R., Bagheri, V., Razavi, M. S., Momtazi‐Borojeni, A. A., Sahebkar, A., & Gholamin, M. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25759 · Cited by 225 · see citing works

Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer

Wen, Y., Xiong, X., Zaytseva, Y. Y., Napier, D. L., Vallee, E., Li, A. T., Wang, C., Weiss, H. L., Evers, B. M., & Gao, T. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0330-6 · Cited by 222 · see citing works

An Overview of Lipid Droplets in Cancer and Cancer Stem Cells

Tirinato, L., Pagliari, F., Limongi, T., Marini, M., Falqui, A., Seco, J. C., Candeloro, P., Liberale, C., & Fabrizio, E. M. D. (2017) · Stem Cells International · doi:10.1155/2017/1656053 · Cited by 214 · see citing works

Chromatin regulatory mechanisms and therapeutic opportunities in cancer

Valencia, A. M., & Kadoch, C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0258-1 · Cited by 205 · see citing works

Cell plasticity in epithelial homeostasis and tumorigenesis

Varga, J., & Greten, F. R. (2017) · Nature Cell Biology · doi:10.1038/ncb3611 · Cited by 204 · see citing works

Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy

Zhang, S., Cui, B., Lai, S. H., Liu, G., Ghia, E. M., Widhopf, G. F., Zhang, Z., Wu, C. C. N., Chen, L., Wu, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419599111 · Cited by 188 · see citing works

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Vora, P., Venugopal, C., Salim, S. K., Tatari, N., Bakhshinyan, D., Singh, M., Seyfrid, M., Upreti, D., Rentas, S., Wong, N., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.04.008 · Cited by 188 · see citing works

Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer

Toden, S., Tran, H.-M. T., Tovar-Camargo, O. A., Okugawa, Y., & Goel, A. (2016) · Oncotarget · doi:10.18632/oncotarget.7567 · Cited by 187 · see citing works

TNIK inhibition abrogates colorectal cancer stemness

Masuda, M., Uno, Y., Ohbayashi, N., Ohata, H., Mimata, A., Kukimoto-Niino, M., Moriyama, H., Kashimoto, S., Inoue, T., Goto, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms12586 · Cited by 168 · see citing works

Head and neck cancer: Current challenges and future perspectives

Bhat, G. R., Hyole, R. G., & Li, J. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.05.002 · Cited by 159 · see citing works

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse

Jia, L., Zhang, W., & Wang, C. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.022 · Cited by 158 · see citing works

Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets

Sato, R., Semba, T., Saya, H., & Arima, Y. (2016) · Stem Cells · doi:10.1002/stem.2406 · Cited by 157 · see citing works

PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3

Benítez, J. A., Ma, J., D’Antonio, M., Boyer, A. D., Camargo, M. F., Zanca, C., Kelly, S., Khodadadi‐Jamayran, A., Jameson, N. M., Andersen, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15223 · Cited by 143 · see citing works

Epithelial Mesenchymal Transition: a double‐edged sword

Barrière, G., Fici, P., Gallerani, G., Fabbri, F., & Rigaud, M. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0055-4 · Cited by 142 · see citing works

Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody

Zhang, S., Zhang, H., Ghia, E. M., Huang, J., Wu, L., Zhang, J., Lam, S., Yang, L., He, J., Cui, B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816262116 · Cited by 143 · see citing works

C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling

Zhu, P., Wang, Y., Du, Y., He, L., Huang, G., Zhang, G., Yan, X., & Fan, Z. (2015) · Nature Communications · doi:10.1038/ncomms8122 · Cited by 141 · see citing works

Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer

Liu, Y., Yang, M., Luo, J., & Zhou, H. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-00087-0 · Cited by 135 · see citing works

Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells

Regan, J. L., Schumacher, D., Staudte, S., Steffen, A., Haybaeck, J., Keilholz, U., Schweiger, C., Golob‐Schwarzl, N., Mumberg, D., Henderson, D. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.025 · Cited by 131 · see citing works

MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer

Yang, A., Qin, S., Schulte, B. A., Ethier, S. P., Tew, K. D., & Wang, G. Y. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3452 · Cited by 127 · see citing works

Bmi-1: At the crossroads of physiological and pathological biology

Bhattacharya, R., Mustafi, S. B., Street, M., Dey, A., & Dwivedi, S. K. D. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.04.001 · Cited by 126 · see citing works

Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

Du, L., Li, Y., Fakih, M., Wiatrek, R. L., Duldulao, M. P., Chen, Z., Chu, P. G., García‐Aguilar, J., & Chen, Y. (2016) · Nature Communications · doi:10.1038/ncomms12326 · Cited by 121 · see citing works

A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced Immunotherapy

Wu, Y., Chang, X., Yang, G., Chen, L., Wu, Q., Gao, J., Tian, R., Mu, W., Gooding, J. J., Chen, X., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210787 · Cited by 120 · see citing works

A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers

Smith, B. A., Balanis, N. G., Nanjundiah, A., Sheu, K. M., Tsai, B. L., Zhang, Q., Park, J. W., Thompson, M. J., Huang, J., Witte, O. N., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.062 · Cited by 114 · see citing works

The role of TP53 in acute myeloid leukemia: Challenges and opportunities

Barbosa, K., Li, S., Adams, P. D., & Deshpande, A. J. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22796 · Cited by 115 · see citing works

Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling

Lei, Z.-J., Wang, J., Xiao, H.-L., Guo, Y., Wang, T., Li, Q., Liu, L., Luo, X., Fan, L.-L., Li, L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.129 · Cited by 116 · see citing works

Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications

Wang, W. T., Qin, J., Voruganti, S., Nag, S. A., Zhou, J., & Zhang, R. (2015) · Medicinal Research Reviews · doi:10.1002/med.21358 · Cited by 112 · see citing works

Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms

Wang, G., Zhang, M., Cheng, M., Wang, X., Li, K., Chen, J., Chen, Z., Chen, S., Chen, J., Xiong, G., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.009 · Cited by 109 · see citing works

Signaling pathways in HPV‐associated cancers and therapeutic implications

Chen, J. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1823 · Cited by 107 · see citing works

The CDX1–microRNA-215 axis regulates colorectal cancer stem cell differentiation

Jones, M. F., Hara, T., Francis, P., Li, X. L., Bilke, S., Zhu, Y. J., Pineda, M. A., Subramanian, M., Bodmer, W. F., & Lal, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503370112 · Cited by 106 · see citing works

c‑Myc maintains the self‑renewal and chemoresistance properties of colon cancer stem cells

Zhang, H., Wang, P., Lu, M., Zhang, S., & Zheng, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.10081 · Cited by 106 · see citing works

EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model

Wang, T., Gantier, M. P., Xiang, D., Bean, A. G. D., Bruce, M. P., Zhou, S., Khasraw, M., Ward, A. C., Wang, L., Wei, M. Q., et al. (2015) · Theranostics · doi:10.7150/thno.11692 · Cited by 106 · see citing works

The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition

Klauzińska, M., de Castro, N. P., Rangel, M. C., Spike, B. T., Gray, P. C., Bertolette, D. C., Cuttitta, F. F., & Salomon, D. S. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.08.003 · Cited by 104 · see citing works

NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer

Karki, R., Malireddi, R. K. S., Zhu, Q., & Kanneganti, T. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1317414 · Cited by 103 · see citing works

CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer

Gao, S., Soares, F., Wang, S., Wong, C. C., Chen, H., Yang, Z., Liu, W., Go, M. Y. Y., Ahmed, M., Zeng, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01882-7 · Cited by 98 · see citing works

Inhibition of BMI1 induces autophagy-mediated necroptosis

Dey, A., Mustafi, S. B., Saha, S., Kumar Dhar Dwivedi, S., Mukherjee, P., & Bhattacharya, R. (2016) · Autophagy · doi:10.1080/15548627.2016.1147670 · Cited by 97 · see citing works

MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin

Gallo, M., Coutinho, F. J., Vanner, R. J., Gayden, T., Mack, S. C., Murison, A., Remke, M., Ren, L., Takayama, N., Desai, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.005 · Cited by 97 · see citing works

Chemotherapy targeting cancer stem cells.

Liu, H., Lv, L. L., & Yang, K. (2015) · PubMed Central · Cited by 94 · see citing works

The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells

Nishida, Y., Maeda, A., Kim, M. J., Cao, L., Kubota, Y., Ishizawa, J., Al-Rawi, A., Kato, Y., Iwama, A., Fujisawa, M., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.8 · Cited by 96 · see citing works

Unravelling the genomic targets of small molecules using high-throughput sequencing

Rodriguez, R., & Miller, K. M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3796 · Cited by 94 · see citing works

Epigenetics in multiple myeloma: From mechanisms to therapy

Alzrigat, M., Párraga, A. A., & Jernberg‐Wiklund, H. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.09.007 · Cited by 95 · see citing works

Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer

Xiong, X., Wen, Y., Fairchild, R., Zaytseva, Y. Y., Weiss, H. L., Evers, B. M., & Gao, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02936-6 · Cited by 94 · see citing works

Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies

Qureshi-Baig, K., Ullmann, P., Haan, S., & Letellier, E. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0602-2 · Cited by 99 · see citing works

cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo

Gu, X., Wei, Y., Fan, Q., Sun, H., Cheng, R., Zhong, Z., & Deng, C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.005 · Cited by 92 · see citing works

Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells

Wuputra, K., Ku, C., Wu, D., Lin, Y., Saito, S., & Yokoyama, K. K. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01584-0 · Cited by 100 · see citing works

Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer

Jeusset, L. M., & McManus, K. J. (2019) · Cells · doi:10.3390/cells8020165 · Cited by 88 · see citing works

A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

Francescangeli, F., Contavalli, P., Angelis, M. L. D., Careccia, S., Signore, M., Haas, T. L., Salaris, F., Baiocchi, M., Boe, A., Giuliani, A., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1505-4 · Cited by 89 · see citing works

Context-dependent actions of Polycomb repressors in cancer

Koppens, M. A. J., & van Lohuizen, M. (2015) · Oncogene · doi:10.1038/onc.2015.195 · Cited by 86 · see citing works

The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor

Ouyang, L., Yan, B., Liu, Y., Mao, C., Wang, M., Liu, N., Wang, Z., Liu, S., Shi, Y., Chen, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0181-3 · Cited by 87 · see citing works

BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1

Zhu, S. L., Zhao, D., Lin, Y., Jiang, W., Kim, J., Gu, B., Liu, Q., Wang, R., Xia, B., Zhao, J. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02863-3 · Cited by 86 · see citing works

Prostate Luminal Progenitor Cells in Development and Cancer

Zhang, D., Zhao, S., Li, X., Kirk, J. S., & Tang, D. G. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.09.003 · Cited by 84 · see citing works

Epigenetic regulation of cancer stem cell formation and maintenance

French, R., & Pauklin, S. (2020) · International Journal of Cancer · doi:10.1002/ijc.33398 · Cited by 83 · see citing works

Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy

He, J., Lee, H., Saha, S., Ruan, D., Guo, H., & Chan, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1512-6 · Cited by 84 · see citing works

Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis

Ito, H., Tanaka, S., Akiyama, Y., Shimada, S., Adikrisna, R., Matsumura, S., Aihara, A., Mitsunori, Y., Ban, D., Ochiai, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146564 · Cited by 81 · see citing works

Microfluidic Manipulation of Core/Shell Nanoparticles for Oral Delivery of Chemotherapeutics: A New Treatment Approach for Colorectal Cancer

Hasani‐Sadrabadi, M. M., Taranejoo, S., Dashtimoghadam, E., Bahlakeh, G., Majedi, F. S., VanDersarl, J. J., Janmaleki, M., Sharifi, F., Bertsch, A., Hourigan, K., et al. (2016) · Advanced Materials · doi:10.1002/adma.201502697 · Cited by 81 · see citing works

Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1

Darwish, N. H. E., Sudha, T., Godugu, K., Elbaz, O., Abdel-ghaffar, H. A., Hassan, E. E. A., & Mousa, S. A. (2016) · Oncotarget · doi:10.18632/oncotarget.11063 · Cited by 81 · see citing works

Selective depletion of metastatic stem cells as therapy for human colorectal cancer

Céspedes, M. V., Unzueta, U., Aviñó, A. M., Gallardo, A., Álamo, P., Sala, R., Sánchez‐Chardi, A., Casanova, I., Mangues, M. A., Pousa, A. L., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708772 · Cited by 80 · see citing works

Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells

Wang, T., Qin, Z., Wen, L., Guo, Y., Liu, Q., Lei, Z., Pan, W. X., Liu, K., Wang, X., Lai, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0095-6 · Cited by 82 · see citing works

miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells

Wang, J., Lei, Z., Guo, Y., Wang, T., Qin, Z., Xiao, H., Fan, L., Chen, D., Bian, X., Liu, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5635 · Cited by 78 · see citing works

Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt–β-catenin–mediated intestinal tumor growth and regeneration

Phesse, T. J., Büchert, M., Stuart, E. C., Flanagan, D. J., Faux, M. C., Afshar‐Sterle, S., Walker, F., Zhang, H., Nowell, C. J., Jorissen, R. N., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005411 · Cited by 76 · see citing works

Interfacial structure, properties and design

Yoo, M. H., Clark, W. A. T., & Briant, C. L. (1988) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 77 · see citing works

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer

Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82 · see citing works

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer

Dwivedi, S. K. D., Mustafi, S. B., Mangala, L. S., Jiang, D., Pradeep, S., Rodriguez‐Aguayo, C., Ling, H. Y., Ivan, C., Mukherjee, P., Călin, G. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7618 · Cited by 76 · see citing works

Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer

Moore, P. A., Shah, K., Yang, Y., Alderson, R. F., Roberts, P., Long, V., Liu, D., Li, J. C., Burke, S., Ciccarone, V. C., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1086 · Cited by 76 · see citing works

An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

De Angelis, M. L., Francescangeli, F., Nicolazzo, C., Signore, M., Giuliani, A., Colace, L., Boe, A., Magri, V., Baiocchi, M., Ciardi, A., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02263-y · Cited by 75 · see citing works

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells

Liu, X., Chen, X., Rycaj, K., Chao, H., Deng, Q., Jeter, C. R., Liu, C., Honorio, S., Li, H., Davis, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4260 · Cited by 75 · see citing works

Reversing tumor stemness via orally targeted nanoparticles achieves efficient colon cancer treatment

Xu, J., Zhang, Y., Xu, J., Wang, M., Liu, G., Wang, J., Zhao, X., Qi, Y., Shi, J. Y., Cheng, K., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119247 · Cited by 73 · see citing works

PROX1 Promotes Metabolic Adaptation and Fuels Outgrowth of Wnthigh Metastatic Colon Cancer Cells

Ragusa, S., Cheng, J., Ivanov, K. I., Zangger, N., Ceteci, F., Bernier‐Latmani, J., Milatos, S., Joseph, J., Tercier, S., Bouzourène, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.041 · Cited by 73 · see citing works

The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer

Yang, P., Hu, Y., & Zhou, Q. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191113113110 · Cited by 75 · see citing works

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

Ko, T. K., Javed, A., Lee, K. L., Pathiraja, T. N., Liu, X., Malik, S., Soh, S. X., Heng, X. T., Takahashi, N., Tan, J. H. J., et al. (2020) · Blood · doi:10.1182/blood.2020004834 · Cited by 72 · see citing works

Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution

Francescangeli, F., Angelis, M. L. D., Rossi, R., Cuccu, A., Giuliani, A., Maria, R. D., & Zeuner, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10092-4 · Cited by 77 · see citing works

Cancer stem cells: a potential target for cancer therapy

Qiu, H. Y., Fang, X., Luo, Q., & Ouyang, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1920-4 · Cited by 71 · see citing works

MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells

Rajabi, H. N., Hiraki, M., & Kufe, D. W. (2018) · Oncogene · doi:10.1038/s41388-017-0096-9 · Cited by 70 · see citing works

Oxidative stress induces senescence in breast cancer stem cells

Zhong, G., Qin, S., Townsend, D. M., Schulte, B. A., Tew, K. D., & Wang, G. Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.098 · Cited by 72 · see citing works

The role of SOX family transcription factors in gastric cancer

Abadi, A. J., Zarrabi, A., Hashemi, F., Zabolian, A., Najafi, M., Entezari, M., Hushmandi, K., Aref, A. R., Khan, H. Z., Makvandi, P., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.202 · Cited by 70 · see citing works

Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair

Qin, S., He, X., Lin, H., Schulte, B. A., Zhao, M., Tew, K. D., & Wang, G. Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.006 · Cited by 68 · see citing works

Multifaceted Interpretation of Colon Cancer Stem Cells

Hatano, Y., Fukuda, S., Hisamatsu, K., Hirata, A., Hara, A., & Tomita, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071446 · Cited by 69 · see citing works

Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain

Shukla, S., Ying, W., Gray, F. L. V., Yao, Y., Simes, M. L., Zhao, Q., Miao, H. Z., Cho, H. J., Gónzález-Alonso, P., Winkler, A., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00815-5 · Cited by 66 · see citing works

Abstract 3496: Self-renewal as a therapeutic target in human colorectal cancer

Kreso, A., van Galen, P., Davis, T. W., SZENTGYORGYI, E. M., O'Brien, C. A., & Dick, J. E. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3496

Targeting self-renewal, an Achilles' heel of cancer stem cells

Wicha, M. S. (2014) · Nature Medicine · doi:10.1038/nm.3434 · Cited by 53 · see citing works

Targeting Cancer Stem Cells in Colorectal Cancer

Azvolinsky, A. (2013)

A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer

Wang, J., Xing, Y., Wang, Y., He, Y., Wang, L., Peng, S., Yang, L.-F., Xie, J., Li, X., Qiu, W., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1392-8 · Cited by 31 · see citing works

BMI1 Is a Therapeutic Target in Colorectal Cancer

(2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2013-272